Retatrutide Research Guide: Triple Incretin Agonism & the Next Frontier in Metabolic Research

What Makes Retatrutide Unique?

Retatrutide engages GLP-1R, GIPR, and GCGR simultaneously. No prior incretin research compound targets all three, giving it a pharmacological profile researchers can’t replicate with existing tools.

⚠️ Research Use Only
All products sold by FenaLife are intended strictly for laboratory and academic research purposes. Not for human consumption, injection, or ingestion. These statements have not been evaluated by the FDA.
Retatrutide Molecular Profile
PropertyValue
DeveloperEli Lilly (LY3437943)
MechanismGLP-1R / GIPR / GCGR triple agonist
Structure36-amino acid peptide with C20 fatty acid
Half-life~6 days
ClassificationTriple incretin agonist / triagonist
Triple Receptor Mechanism
GLP-1R Agonism
Insulin secretion, glucagon suppression, delayed gastric emptying, hypothalamic appetite signalling — shared with semaglutide and tirzepatide.
GIPR Agonism
Glucose-dependent insulin secretion augmentation, adipose tissue metabolism, potential direct CNS appetite effects.
GCGR Agonism
Novel component: promotes hepatic fatty acid oxidation, reduces liver fat (NAFLD relevance), increases thermogenesis and basal metabolic rate.
Why Glucagon Receptor Activation Is Beneficial Here
In the presence of GLP-1R agonism (which prevents hyperglycemia), GCGR activation primarily drives hepatic fat reduction and energy expenditure — not glycemic dysregulation. Research hypothesis: the combination provides metabolic benefits not achievable by either system alone.
Published Weight Reduction Data — GLP-1 Class (Phase 2/3)
Semaglutide 2.4mg (STEP-1)~15% at 68 weeks
Tirzepatide 15mg (SURMOUNT-1)~22.5% at 72 weeks
Retatrutide 12mg (Phase 2, NEJM 2023)~24% at 48 weeks
Incretin Compound Comparison
CompoundGLP-1RGIPRGCGRKey Application
SemaglutideSingle incretin research
TirzepatideDual incretin comparison
RetatrutideTriple agonism, NAFLD, energy expenditure
Retatrutide Storage & Reconstitution
1
Store lyophilized at −20°C
Protect from moisture and light.
2
Reconstitute with BAC water
Inject slowly against vial wall. Swirl gently — do not shake.
3
Store reconstituted at 2–8°C
Use within 28 days. Avoid freeze-thaw cycles.

FenaLife carries retatrutide in 10mg, 30mg, and 50mg formats.

Conclusion

Retatrutide lets researchers isolate and compare the contributions of GLP-1R, GIPR, and GCGR signalling within a single compound. Browse FenaLife’s metabolic research catalog.

⚠️ Research Use Only
All products sold by FenaLife are intended strictly for laboratory and academic research purposes. Not for human consumption, injection, or ingestion. These statements have not been evaluated by the FDA.

Source Retatrutide at FenaLife

Research-grade, HPLC-verified purity. Fast shipping.

Shop Retatrutide →

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top